The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Reduced suppressive effect of CD4+CD25high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis
Abstract
Immunoregulatory T cells of (CD4+)CD25+ phenotype suppress T cell function and protect rodents from organ-specific autoimmune disease. The human counterpart of this subset of T cells expresses high levels of CD25 and its role in human autoimmune disorders is currently under intense investigation. In multiple sclerosis (MS), a chronic inflammatory disease of the central nervous system (CNS), the activation of circulating self-reactive T cells with specificity for myelin components is considered to be an important disease initiating event. Here, we investigated whether MS is associated with an altered ability of (CD4+)CD25high regulatory T cells (Treg) to confer suppression of myelin-specific immune responses. Whereas Treg frequencies were equally distributed in blood and cerebrospinal fluid of MS patients and did not differ compared to healthy controls, the suppressive potency of patient-derived (CD4+)CD25high T lymphocytes was impaired. Their inhibitory effect on antigen-specific T cell proliferation induced by human recombinant myelin oligodendrocyte protein as well as on immune responses elicited by polyclonal and allogeneic stimuli was significantly reduced compared to healthy individuals. The effect was persistent and not due to responder cell resistance or altered survival of Treg, suggesting that a defective immunoregulation of peripheral T cells mediated by (CD4+)CD25high T lymphocytes promotes CNS autoimmunity in MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
CD4+CD25+ suppressor T cells: more questions than answers
Shevach, E. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri821 · Cited by 2,110
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher-Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,859
Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Jonuleit, H., Schmitt, E., Stassen, M., Tuettenberg, A., Knop, J., & Enk, A. H. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1285 · Cited by 1,255
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,252
Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., & Schuler, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1303 · Cited by 1,139
Levings, M. K., Sangregorio, R., & Roncarolo, M.-G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1295 · Cited by 967
Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System
Steinman, M. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81107-1 · Cited by 903
Kohm, A. P., Carpentier, P. A., Anger, H. A., & Miller, S. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.9.4712 · Cited by 782
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin‐Su, K., Ten, S., Sanz, M. M., Exley, M. A., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13605 · Cited by 640
Mendel, I., de Rosbo, N. K., & Ben‐Nun, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250723 · Cited by 601
The enemy within: keeping self-reactive T cells at bay in the periphery
Walker, L. S. K., & Abbas, A. K. (2002) · Nature Reviews Immunology · doi:10.1038/nri701 · Cited by 596
Sugiyama, H., Gyulai, R., Toichi, E., Garaczi, E., Shimada, S., Stevens, S. R., McCormick, T. S., & Cooper, K. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.164 · Cited by 570
Multiple immuno-regulatory defects in type-1 diabetes
Kukreja, A., Cost, G., Marker, J., Zhang, C., Sun, Z., Lin-Su, K., Ten, S., Sanz, M., Exley, M., Wilson, B., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213605 · Cited by 566
Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activityin vitro
Stephens, L. A., Mottet, C., Mason, D., & Powrie, F. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1247::aid-immu1247>3.0.co;2-m · Cited by 486
Cao, D., Malmström, V., Baecher‐Allan, C., Hafler, D., Klareskog, L., & Trollmo, C. (2003) · European Journal of Immunology · doi:10.1002/immu.200390024 · Cited by 439
Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis-prone population
Taams, L. S., Smith, J., Rustin, M. H., Salmon, M., Poulter, L. W., & Akbar, A. N. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200104)31:4<1122::aid-immu1122>3.0.co;2-p · Cited by 436
Quantification of regulatory T cells in patients with systemic lupus erythematosus
Crispin, J. C., Martı́nez, A., & Alcocer-Varela, J. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00121-5 · Cited by 408
de Kleer, I. M., Wedderburn, L. R., Taams, L. S., Patel, A., Varsani, H., Klein, M., de Jager, W., Pugayung, G., Giannoni, F., Rijkers, G., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.10.6435 · Cited by 400
Kriegel, M. A., Lohmann, T., Gabler, C., Blank, N., Kalden, J. R., & Lorenz, H.-M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032158 · Cited by 351
Hazenberg, M. D., Verschuren, M. C., Hamann, D., Miedema, F., & Dongen, J. J. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100271 · Cited by 336
Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells
Bensinger, S. J., Walsh, P. T., Zhang, J., Carroll, M., Parsons, R., Rathmell, J. C., Thompson, C. B., Burchill, M. A., Farrar, M. A., & Turka, L. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5287 · Cited by 289
Progress in determining the causes and treatment of multiple sclerosis
Noseworthy, J. H. (1999) · Nature · doi:10.1038/399a040 · Cited by 278
Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells
Taams, L. S., Vukmanovic‐Stejic, M., Smith, J., Dunne, P. J., Fletcher, J. M., Plunkett, F. J., Ebeling, S. B., Lombardi, G., Rustin, M. H. A., Bijlsma, J. W. J., et al. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200206)32:6<1621::aid-immu1621>3.0.co;2-q · Cited by 237
Characterization of human CD25+ CD4+ T cells in thymus, cord and adult blood
Wing, K., Ekmark, A., Karlsson, H., Rudin, A., & Suri‐Payer, E. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01412.x · Cited by 225
Self-citationBoyer, O., Saadoun, D., Abriol, J., Dodille, M., Piette, J.-C., Cacoub, P., & Klatzmann, D. (2004) · Blood · doi:10.1182/blood-2003-07-2598 · Cited by 223
Lindert, R.-B., Haase, C. G., Brehm, U., Linington, C., Wekerle, H., & Hohlfeld, R. (1999) · Brain · doi:10.1093/brain/122.11.2089 · Cited by 167
T Lymphocyte Tolerance: From Thymic Deletion to Peripheral Control Mechanisms
Stockinger, B. (1998) · Advances in Immunology · doi:10.1016/s0065-2776(08)60404-6 · Cited by 159
Hug, A., Korporal, M., Schröder, I., Haas, J., Glatz, K., Storch-Hagenlocher, B., & Wildemann, B. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.432 · Cited by 155
Self-citationT-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls
Hellings, N., Bar�e, M., Verhoeven, C., D'hooghe, M. B., Medaer, R., Bernard, C. C. A., Raus, J., & Stinissen, P. (2001) · Journal of Neuroscience Research · Cited by 142
Wing, K., Lindgren, S., Kollberg, G., Lundgren, A., Harris, R. A., Rudin, A., Lundin, S. B., & Suri‐Payer, E. (2003) · European Journal of Immunology · doi:10.1002/eji.200323701 · Cited by 97
Self-citationRelease and Intercellular Transfer of Cell Surface CD81 Via Microparticles
Fritzsching, B., Schwer, B., Kartenbeck, J., Pedal, A., Hořejší, V., & Ott, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.10.5531 · Cited by 90
Self-citationAutoreactivity to myelin antigens: myelin/oligodendrocyte glycoprotein is a prevalent autoantigen
Villoslada, P., Shih, A., Shao, L., Genain, C. P., & Hauser, S. L. (1999) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(99)00099-5 · Cited by 67
IL-7-enhanced T-cell response to myelin proteins in multiple sclerosis
Traggiai, E., Biagioli, T., Rosati, E., Ballerini, C., Mazzanti, B., Nun, A. B., Massacesi, L., & Vergelli, M. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00433-7 · Cited by 36
Cited by
Risk Alleles for Multiple Sclerosis Identified by a Genomewide Study
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa073493 · Cited by 1,746
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N., & Mills, K. H. G. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04143.x · Cited by 945
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation
Korn, T., Reddy, J., Gao, W., Bettelli, E., Awasthi, A., Petersen, T. R., Bäckström, B. T., Sobel, R. A., Wucherpfennig, K. W., Strom, T. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1564 · Cited by 811
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Buckner, J. H. (2010) · Nature Reviews Immunology · doi:10.1038/nri2889 · Cited by 789
Metadata
- Authors
- Haas, J., Hug, A., Viehöver, A., Fritzsching, B., Falk, C. S., Filser, A., Vetter, T., Milkova, L., Korporal, M., Fritz, B., Storch-Hagenlocher, B., Krammer, P. H., Suri-Payer, E., & Wildemann, B.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2005-11
- Volume
- 35
- Issue
- 11
- Pages
- 3343-3352
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2018011490
- Cited by
- 449
- References
- 41
- FWCI
- 15.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.